Sylvester Launches International Neuro-oncology Scholars Program

Reading Time: 2 minutes

Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, has launched an International Neuro-oncology Scholars Program (INOSP) that allows neurosurgery trainees to participate with internationally renowned brain tumor experts in other countries to increase their experience.

The goal is to enhance education and facilitate multi-institutional collaboration. The INOSP program is made possible by a generous gift from a grateful donor family. The plan is to support four rotations each year.

Dr. Charles Teo, left, with neurosurgery fellow Dr. Daniel Eichberg.

“INOSP represents a unique resource offered to our fellows to visit and learn from world-renowned experts in neurosurgical oncology,” said Ricardo J. Komotar, M.D., professor of neurosurgery, director of the UM Brain Tumor Initiative, director of surgical neuro-oncology, and director of the neuro-oncology fellowship program. “The goal of the program is to further enhance their neurosurgical training so that they may be able to translate these techniques to our patients. With this international collaboration, we ultimately hope to improve clinical outcomes and enhance surgical education.”

The inaugural recipient of INOSP was neurosurgery fellow Daniel Eichberg, M.D., who spent two weeks in Sydney, Australia, learning from highly accomplished neurosurgeons Charles Teo and Michael Sughrue at Prince of Wales Hospital.

“The opportunity to learn minimally invasive keyhole approaches for complex brain and skull base tumors in one-on-one training sessions from two of the most experienced neurosurgeons in these techniques was a powerful experience and augmented my skillset for cranial neurosurgery,” said Dr. Eichberg.

Dr. Sughrue and Dr. Teo have developed the world’s most advanced technology for mapping the brain’s functional and structural connectivity, which may be markedly abnormal in patients with brain tumors. Providing a better understanding of an individual’s connectome may have a critical impact on brain tumor surgical outcomes by minimizing postoperative deficits, predicting recovery, and maximizing the amount of tumor that can safely be removed during surgery.

Furthermore, this brain mapping technology uses machine learning and artificial intelligence techniques to guide non-invasive transcranial magnetic stimulation (TMS)-based neuro-interventional rehabilitation to improve strength and speech deficits in postoperative brain tumor patients.

As a result of the international collaboration fostered by INOSP, Sylvester and the University of Miami Department of Neurosurgery will partner with the Sydney team in the Glioma Connectome Project, an endeavor that seeks to learn how gliomas cause the brain to reorganize its connectome, and will initiate a TMS Neuro-interventional Rehabilitation prospective clinical trial.

“Not only are we now able to give our neurosurgical fellows access to additional world-renowned brain tumor experts and each of their unique skills, we are also seeing that these new international relationships lead to groundbreaking global collaborative research and enhanced clinical trials that will continue to allow us at Sylvester to be able to provide the most advanced and world-class brain tumor treatments possible to our patients,” said program co-director Michael E. Ivan M.D., M.B.S., assistant professor of neurosurgery.